P UMPMASTER AND G LUCOMMANDER THE FAR SIDE OF THE DIABETES WORLD Presented by Paul Davidson MD at the MiniMed Symposium Atlanta, GA December 13, 2003.

Slides:



Advertisements
Similar presentations
© 2004, John Walsh, PA, CDE Intelligent Devices A Smart Pen demonstrates possibilities for intelligent diabetes devices by John Walsh, P.A., C.D.E. Smart.
Advertisements

Advanced Pumping. Objectives: Identify situations to utilize temporary basal rate in pump therapy patients. Identify examples of when to use combination.
Monitoring diabetes Diabetes Outreach (March 2011)
Introducing The SHINE Trial (Stroke Hyperglycemia Insulin Network Effort) An Overview for Clinical Nurses NIH-NINDS U01 NSO69498.
Boluses, basals and corrections – Getting the doses right Stephen W. Ponder MD, FAAP, CDE Scott & White Clinic Temple, Round Rock and College Station.

Canadian Diabetes Assocaition Clinical Practice Guidelines Pharmacotherapy in Type 1 Diabetes Chapter 12 Angela McGibbon, Cindy Richardson, Cheri Hernandez,
Insulin Pump What to tell your patient!! Prakash Abraham Isla Fairley.
Utilizing Insulin Pump Therapy in Challenging Populations Bruce W. Bode, MD, FACE Atlanta Diabetes Associates Atlanta, Georgia.
Putting Pump Policies Into Practice- Case Study Conference Call Elizabeth Blair, ANP-BC,CDE Joyce Lekarcyk, RN, CDE.
Intensive Insulin Therapy Advances in MDI and CSII Bruce W. Bode, MD, FACE Atlanta Diabetes Associates Atlanta, Georgia.
Insulin Pump Therapy Case Studies Sandra Weber, MD and Bruce W. Bode, MD.
Diabetes Control in Youth: The American Experience Georgeanna J. Klingensmith, MD Keystone Colorado July 2008.
Carbohydrate Counting in Youth with Type 1 Diabetes Management of Diabetes in Youth, Biennial Conference of the Barbara Davis Center for Childhood Diabetes.
You Have Diabetes! New Diagnosis Scared 15 year old… What are your fears? Who are your stakeholders?
1-800-DIABETES DIABETES CARE TASKS AT SCHOOL: What Key Personnel Need to Know DIABETES CARE TASKS AT SCHOOL: What Key Personnel Need to.
Helping Belton ISD Students Succeed What Every BISD Staff Needs to Know About: Helping Belton ISD Students Succeed What Every BISD Staff Needs to Know.
Clinical Protocol Using Insulin Pump Easy Guideline for Initiating Insulin Pumps on Type 2 Diabetes Patients.
Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 9: Special Types of Intravenous Calculations.
Counting Carbohydrates and Dosing Insulin for School Nurses
INSULIN THERAPY IN TYPE 1 DIABETES
Are You A Candidate For An Insulin Pump?
Management of Inpatient Blood Glucose at Temple Housestaff Orientation 2014.
Diabetes Management in the Hospital: Case Studies Bruce W. Bode, MD, FACE Atlanta Diabetes Associates Atlanta, Georgia.
1-800-DIABETES DIABETES CARE TASKS AT SCHOOL: What Key Personnel Need to Know DIABETES CARE TASKS AT SCHOOL: What Key Personnel Need to.
Diabetes Technology Update
Diabetes Management in Hospital Orlando, May 31, 2003 Paul C. Davidson, MD, FACE Atlanta Diabetes Associates Atlanta, Georgia.
Closed-Loop Insulin Delivery in Children
Diabetes Management in the Hospital Bruce W. Bode, MD, FACE Atlanta Diabetes Associates Atlanta, Georgia.
Basal and Meal Time Insulin Case Study
OnsetPeakDuration Rapid Acting Lispro (Humalog) min3-5 hours Aspart (Novolog)15-30 min1-3 hours3-5 hours Intermediate Acting NPH1-4 hours5-10.
Combination Therapy for Type 2 Diabetes Springfield, IL, Nov 15, 2003 Paul Davidson, MD, FACE Atlanta Diabetes Associates Atlanta, Georgia.
Bradford Insulin Pump Service Gill Atherton Sandra Dudding Diabetes Specialist Nurses.
Basal Bolus: The Strategy for Managing All Diabetes Paul Davidson, MD, FACE Atlanta Diabetes Associates Atlanta, Georgia Presented in San Antonio, May.
Davida F. Kruger, MSN,APN-BC,BC-ADM Certified Nurse Practitioner Division of Endocrinology, Diabetes, Bone and Mineral Disorders Henry Ford Health System.
1 Carb Counting and Insulin Administration Module Georgia Hospital Association Diabetes Special Interest Group.
New Insulin Formulations
Diabetes: What’s New? What’s Next? Robert P. Hoffman, M.D. Grand Rounds June 1, 2007.
Diabetes Technology and Insulin Therapy Bruce W. Bode, MD, FACE Atlanta Diabetes Associates Atlanta, Georgia.
Basal Bolus: The Strategy for Managing All Diabetes Fall, 2003 Paul Davidson, MD, FACE Atlanta Diabetes Associates Atlanta, Georgia.
Combination Therapy for Type 2 Diabetes Paul Davidson, MD, FACE Atlanta Diabetes Associates Atlanta, Georgia Presented in Dalton, GA on Aug 14, 2003.
Type I Diabetes Mellitus
INSULIN PUMPS Shelby Polk DNP, FNP-BC, CDE. 2 MANAGEMENT OF DIABETES IN SCHOOLS Exercise Legal Rights Health & Learning Nutrition Insulin Administration.
50% Basal Total Daily Dose Split to mimic Euglycemic control 50% Bolus Establishing Starting Basal and Bolus Dosing Based on Pre-Meal Readings and Carb.
TALK DIABETES November 13, 2015 Pumping Insulin 101 Bonnie Stone-Hope RN, CDE, BA.
1 Empowerment Course Presenters: Melba Mensch Course Facilitator Dr Mary Ho CMO and Course Facilitator Dr. Tuan Quach Diabetes Specialist Rosalie Arnold.
Elizabeth DeRobertis, MS, RD, CDN, CDE, CPT Director of The Nutrition Center, Scarsdale Medical Group
Safety and Efficacy of Sitagliptin Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes A pilot, randomized,
Xiali Hei, Xiaojiang Du, Shan Lin Temple University
Clarification of Pump Orders from Barbara Davis Center Diabetes Resource Nurse Winter/Spring 2013.
Insulin Pump Therapy Bruce W. Bode, MD and Sandra Weber, MD.
Insulin order sets – only way to order sustained insulin. Separate versions for 1 st time order and revision.
Date of download: 6/24/2016 From: Comparative Effectiveness and Safety of Methods of Insulin Delivery and Glucose Monitoring for Diabetes Mellitus: A Systematic.
1 Establishment of Blood Glucose Monitoring System Using the Internet Diabetes Care 27:478–483, 2004 Long-Term effect of the Internet-Based Glucose Monitoring.
Introduction Subcutaneous insulin absorption is not reproducible and insulin entry directly into the circulation is not linked to glucose sensing Basal.
Key publication slides
Key publication slides
Insulin Delivery Systems Atlanta Diabetes Associates
Insulin Pump Continuation in the Hospital
T1DM: Insulin Initiation
Sequential insulin strategies in type 2 diabetes.
Distribution of the absolute percentage differences of each basal rate estimate to final basal rates. Distribution of the absolute percentage differences.
The means and SDs of the data from all Glucommander runs from 1984 to 1998 are graphed. The means and SDs of the data from all Glucommander runs from 1984.
Approach to starting and adjusting insulin in type 2 diabetes.
Frequency of potential risk of hypoglycemia for each estimate method, defined as a percentage difference between the estimate and final basal rate. Frequency.
Distribution of the percentage differences of each basal rate estimate to final basal insulin rates. Distribution of the percentage differences of each.
A: Subcutaneous insulin therapy may be selected as continuation of ambulatory therapy, as new therapy, or as a transition plan from intravenous infusion.
INSULINS Dr.R.Sajjad december INSULINS Dr.R.Sajjad december 2018.
Insulin Delivery Systems Atlanta Diabetes Associates
Insulin in Type 2 Diabetes
Presentation transcript:

P UMPMASTER AND G LUCOMMANDER THE FAR SIDE OF THE DIABETES WORLD Presented by Paul Davidson MD at the MiniMed Symposium Atlanta, GA December 13, 2003

AIM Formulae (Accurate Insulin Management) Background l CSII dosing is related to a patient’s size l It consists of four parameters: –Total insulin dose per day (TDD) –Basal Insulin as percent of TDD –Bolus insulin for meals Based on CHO to insulin ratio (CIR) –Correction boluses from the correction factor (CF) l A database of 1815 records was used to find the optimal parameters for the most ideally controlled pump patients. l The interaction of the AIM formulae is portrayed as a nomogram.

Materials and Methods Two groups of patients: –Target Group (TG)--183 patients with A1C <7% –Not-to-Target Group (NTG) the remainder of the patients –Individual's slopes determined: Basal versus TDD CF versus 1/TDD –Median of all slopes in the TG was used as the slope for each formula –Slignificant differences between TG and NTG. TDD versus BW CIR versus BW/TDD

AIM Formulae for adults Carbohydrate / Insulin Ratio (CIR) CIR = 2.8 x BodyWeight(lbs) / TDD Correction Factor (CF) CF = 1700 / TDD Basal Insulin Basal = 0.48 x TDD

Starting Total Daily Insulin Dose TDDstart = 0.24 * Wt(lb) n = 199 File: AIM points

Basal Insulin Basal = 0.48 * TDD n = 199 File: AIM points

If HbA 1c is Not to Goal i.e. 6.5% l SMBG –frequency –recording –memory meter l Diet –accurate CHO counting –appropriate CHO/insulin bolusing l l Infusion site areas l l Over-treatment of low BG l l Delayed or under-treatment of high BG

If HbA 1c Not to Goal i.e. 6.5% l SMBG –frequency –recording –memory meter l l Infusion site areas l l Over-treatment of low BG l l Delayed or under-treatment of high BG More than 4/day 2.8 x Wt / TDD 1700 Rule (100-BG) x 0.2 lDiet –accurate CHO counting –appropriate CHO/insulin bolusing

Average 2 BG’s/d Average 12 BG’s/d 24 Blood Glucose Hours Frequency of Blood Glucose Monitoring Effect of Recurrent Adjustment for Increased BG’s

Improvement in HbA 1c with Increased BG Testing

If HbA 1c Not to Goal i.e. 6.5% l SMBG –frequency –recording –memory meter l l Infusion site areas l l Over-treatment of low BG l l Delayed or under-treatment of high BG More than 4/day 2.8 x Wt / TDD 1700 Rule (100-BG) x 0.2 lDiet –accurate CHO counting –appropriate CHO/insulin bolusing

450 Rule vs 2.8 Rule Purpose of rule: Estimate the ratio: carbs / insulin. Start with: CIR = CarbsPerDay / TDD 2.8 Rule : says CarbsPerDay proportional to Wt(lb): CIR = 2.8 * Wt(lb) / TDD 450 Rule : says CarbsPerDay is the same for all people: CIR = 450 / TDD The case for 450 rule: Advocates say it works better for children. The case for 2.8 Rule: Wt(lb) for CarbsPerDay makes better sense than constant. Consistent with 1700 Rule 450 Rule’s scatter chart data look curved. A future study is planned for children. They were under-represented in AIM study.

Median slope = 2.79 Data: file: AIM xls, 179 pts CARBOHYDRATE TO INSULIN RATIO CIR = 2.8 * BW# / TDD for adults

Median slope = 450 Data: file: AIM xls, 179 pts CARBOHYDRATE TO INSULIN RATIO CIR = 450 / TDD

If HbA 1c Not to Goal i.e. 6.5% l SMBG –frequency –recording –memory meter l l Infusion site areas l l Over-treatment of low BG l l Delayed or under-treatment of high BG More than 4/day 2.8 x Wt / TDD 1700 Rule (100-BG) x 0.2 lDiet –accurate CHO counting –appropriate CHO/insulin bolusing

Correction of Hypoglycemia with Glucose 100-BG X 0.2 Grams BeforeAfter Richardson Diabetes :A BG X 0.15 Grams

If HbA 1c Not to Goal i.e. 6.5% l SMBG –frequency –recording –memory meter l l Infusion site areas l l Over-treatment of low BG l l Delayed or under-treatment of high BG More than 4/day 2.8 x Wt / TDD 1700 Rule (100-BG) x 0.2 lDiet –accurate CHO counting –appropriate CHO/insulin bolusing

Correction Factor The 1700 Rule CF = 1705 / TDD n = 199 File: AIM points

1700 Rule Mathematical Model Purpose of 1700 Rule: Estimate Correction Factor (CF) 1700 Rule: says glucose burned per day and body volume are both proportional to Wt(lb). These cancel as shown below: CF = (glucose burned per day)/[(Body volume)*TDD] CF = K1 * Wt(lb) / [ Wt(lb) * TDD] CF = K1 / TDD Statistics give: CF = 1700 / TDD

Correction Factor Carbohydrate to Insulin Ratio CF Curve AIM Nomogram ( CIR = 2.8 Wt / TDD ) ( CF = 1700 / TDD ) Initial Dosing: Plot BW and 25 CIR for BI Plot BW and 12 CIR for TDD Plot BW and TDD for CIR Plot TDD and CF curve for CF 4 3 2

Correction Factor Carbohydrate to Insulin Ratio CF Curve ( CIR = 2.8 Wt / TDD ) ( CF = 1700 / TDD ) CIR TDD BI Weight Example 210 lb.. Man Type 1 Diabetes Starting CSII Poorly controlled HgA1c 8.1% 10 units lispro tid 28 units glargine hs Initial Dosing: Plot BW and 25 CIR for BI Plot BW and 12 CIR for TDD

Correction Factor Carbohydrate to Insulin Ratio CF Curve ( CIR = 2.8 Wt / TDD ) ( CF = 1700 / TDD ) CF TDD Plot TDD and CF curve for CF

Correction Factor Carbohydrate to Insulin Ratio CF Curve ( CIR = 2.8 Wt / TDD ) ( CF = 1700 / TDD ) New TDD New CIR New BI Follow-up One Month Later Weight 200# 4.5 BG’s per day Average BG 172 Current basal 1.2 u/hr (28.8 u/d) TDD from pump 64 units New CF New Weight

AIM “N” Nomogram

Total CIR Daily Wt Wt for adults Insulin CF (kg) (lb) (gm/unit) (unit) (mg/dL/unit) 149 ┼ 329 ┼ ┼ ┼ 313 ┼ ┼ ┼ 298 ┼ ┼ ┼ 284 ┼ ┼ ┼ 270 ┼ ┼ ┼ 258 ┼ ┼ ┼ 245 ┼ ┼ ┼ 234 ┼ ┼ ┼ 222 ┼ ┼ ┼ 212 ┼ ┼ ┼ 202 ┼ ┼ ┼ 192 ┼ ┼ ┼ 183 ┼ ┼ ┼ 174 ┼ ┼ ┼ 166 ┼ ┼ ┼ 158 ┼ ┼ ┼ 151 ┼ ┼ ┼ 143 ┼ 9 45 ┼ ┼ 137 ┼ 8 47 ┼ ┼ 130 ┼ 7 49 ┼ ┼ 124 ┼ 7 52 ┼ ┼ 118 ┼ 6 55 ┼ ┼ 112 ┼ 5 57 ┼ ┼ 107 ┼ 5 60 ┼ ┼ 102 ┼ 5 63 ┼ ┼ 97 ┼ 4 66 ┼ ┼ 92 ┼ 4 70 ┼ ┼ 88 ┼ 3 73 ┼ ┼ 84 ┼ 3 77 ┼ ┼ 80 ┼ 3 81 ┼ ┼ 76 ┼ 3 85 ┼ ┼ 72 ┼ 2 89 ┼ ┼ 69 ┼ 2 93 ┼ ┼ 66 ┼ 2 98 ┼ ┼ 63 ┼ ┼ ┼ 60 ┼ ┼ ┼ 57 ┼ ┼ ┼ 54 ┼ ┼ ┼ 51 ┼ ┼ 14 Accurate Insulin Management (AIM) Nomogram 1.Connect the columns with a straight line between weight and total daily dose of insulin (TDD). 2.Read correction factor (CF) and carbohydrate/insulin ratio (CIR). 3.Basal insulin is one-half total daily dose of insulin.

AIM Study (uncontrolled) l 21 Patients l HbA1c>8 l Competent Self- Monitoring l Pump Veterans l Bi-Weekly Fax and Phone Follow-Up l Three Month Study Davidson et al Diabetes Technology & Therapeutics P<0.0001

PumpMaster A Combined Database Collector and Patient-Treatment Advisor for Interactive Use by Practitioners

Pumpmaster l Day divided into five periods –Sleep, dawn, am, pm, evening l BG monitored initially for each period –Mean and SD l Variation of mean from target –Correction formula used to quantify average insulin need for each period –Summed for day l Program suggests change in insulin for each period balancing change in basal against CIR –Simulates best controlled patients in database

Input Form, Screen 1

Input Form, Screen 2

In development (Patent Pending) Has shown that it lowers A1c Will advise the pump therapist Will advise the pump-wearing diabetic Will encourage more pump prescribing Will facilitate progress to target control Can be programmed into PDA or pump Overview of PumpMaster

Future of Diabetes Management Improvements in Insulin & Delivery l Insulin analogs and inhaled insulin l Smart external pumps l Internal pumps l Real-time sensors l Closed-loop systems l Unconceived-of solutions

QUESTIONS? l For a copy or viewing of these slides –Contact l How can I get use of Glucommander? (Computer-directed IV insulin program) – Available for review on internet, l How can I get use of Pumpmaster? – Contact us expressing interest: